The $100m venture financing of JenaValve Technology was the medical devices industry’s top cross border venture financing deal as total deals worth $439.9m were announced globally in August 2022, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 47.03% over the previous month of $830.41m and a drop of 53.2% when compared with the last 12-month average, which stood at $939.49m.

Comparing cross border venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $312m. At the country level, the US topped the list in terms of deal value at $284m.

In terms of volumes, North America emerged as the top region for medical devices industry cross border venture financing deals globally, followed by Asia-Pacific and then Europe.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The top country in terms of cross border venture financing deals activity in August 2022 was the US with seven deals, followed by the UK with two and China with two.

In 2022, as of August, medical devices cross border venture financing deals worth $6.91bn were announced globally, marking an increase of 32.5% year on year.

medical devices industry cross border venture financing deals in August 2022: Top deals

The top five medical devices industry cross border venture financing deals accounted for 65.8% of the overall value during August 2022.

The combined value of the top five medical devices cross border venture financing deals stood at $289.57m, against the overall value of $439.9m recorded for the month.

The top five medical devices industry cross border venture financing deals of August 2022 tracked by GlobalData were:

1) Andera Partners, Bain Capital Life Sciences, Cormorant Asset Management, Gimv, Innovatus Capital Partners, Peijia Medical, Pictet Alternative Advisors, Qatar Investment Authority, RMM Consulting Group, Valiance Advisors and Venture Incubator’s $100m venture financing deal with JenaValve Technology

2) The $52.57m venture financing of CureApp by The Carlyle Group

3) Novo Holdings’s $50m venture financing deal with MedGenome

4) The $45m venture financing of Theranica by aMoon Partners, Corundum Open Innovation, Lightspeed Management Company, Lionbird, New Rhein Healthcare Investors and Takoa Invest

5) AMED Ventures GP, Cormorant Asset Management, PA MedTech VC Fund, Shifamed Angels and The Capital Partnership – UK’s $42m venture financing deal with Atia Vision